IL300441A - Hybrid amide derivatives of amphotericin b - Google Patents

Hybrid amide derivatives of amphotericin b

Info

Publication number
IL300441A
IL300441A IL300441A IL30044123A IL300441A IL 300441 A IL300441 A IL 300441A IL 300441 A IL300441 A IL 300441A IL 30044123 A IL30044123 A IL 30044123A IL 300441 A IL300441 A IL 300441A
Authority
IL
Israel
Prior art keywords
compound
amb
pct
compounds
acid
Prior art date
Application number
IL300441A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of IL300441A publication Critical patent/IL300441A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL300441A 2020-08-10 2021-08-09 Hybrid amide derivatives of amphotericin b IL300441A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063063655P 2020-08-10 2020-08-10
US202163175771P 2021-04-16 2021-04-16
PCT/US2021/045205 WO2022035752A1 (en) 2020-08-10 2021-08-09 Hybrid amide derivatives of amphotericin b

Publications (1)

Publication Number Publication Date
IL300441A true IL300441A (en) 2023-04-01

Family

ID=80247344

Family Applications (1)

Application Number Title Priority Date Filing Date
IL300441A IL300441A (en) 2020-08-10 2021-08-09 Hybrid amide derivatives of amphotericin b

Country Status (12)

Country Link
US (1) US20230357303A1 (https=)
EP (2) EP4696379A3 (https=)
JP (1) JP7656359B2 (https=)
KR (1) KR20230061405A (https=)
CN (1) CN116323632B (https=)
AU (1) AU2021325676A1 (https=)
CA (1) CA3190997A1 (https=)
ES (1) ES3061451T3 (https=)
IL (1) IL300441A (https=)
MX (1) MX2023001649A (https=)
PT (1) PT4192248T (https=)
WO (1) WO2022035752A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL122086B1 (en) * 1979-04-09 1982-06-30 Politechnika Gdanska Process for preparing amides of antibiotics from the group of polyene macrolides and their derivativesvykh makrolidov i ikh proizvodnykh
AU643141B2 (en) 1991-03-15 1993-11-04 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US6664241B2 (en) * 2000-05-31 2003-12-16 Micrologix Biotech Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
JP6543272B2 (ja) * 2014-05-16 2019-07-10 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイThe Board Of Trustees Of The University Of Illinois 低減された毒性を有するアンホテリシンb誘導体
TWI702223B (zh) * 2014-06-12 2020-08-21 日商塩野義製藥股份有限公司 多烯巨環內酯衍生物
CA3021061C (en) * 2015-04-15 2023-10-24 Martin D. Burke Derivatives of amphotericin b
JP7477177B2 (ja) * 2018-09-07 2024-05-01 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 毒性が低減されたハイブリッドアムホテリシンb誘導体
EP4009985A4 (en) * 2019-08-08 2023-09-06 The Board Of Trustees Of The University Of Illinois HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B

Also Published As

Publication number Publication date
ES3061451T3 (en) 2026-04-01
JP2023537921A (ja) 2023-09-06
EP4192248B1 (en) 2025-12-03
JP7656359B2 (ja) 2025-04-03
WO2022035752A1 (en) 2022-02-17
EP4696379A3 (en) 2026-02-25
EP4192248A1 (en) 2023-06-14
CA3190997A1 (en) 2022-02-17
CN116323632B (zh) 2024-12-31
EP4192248A4 (en) 2024-12-04
AU2021325676A1 (en) 2023-03-30
MX2023001649A (es) 2023-04-24
US20230357303A1 (en) 2023-11-09
KR20230061405A (ko) 2023-05-08
CN116323632A (zh) 2023-06-23
EP4696379A2 (en) 2026-02-18
PT4192248T (pt) 2026-02-11

Similar Documents

Publication Publication Date Title
US11970512B2 (en) Amphotericin B derivatives with improved therapeutic index
CA3149916A1 (en) Hybrid amide derivatives of amphotericin b
US11198705B2 (en) Hybrid Amphotericin B derivatives with reduced toxicity
IL300441A (en) Hybrid amide derivatives of amphotericin b
US20220370486A1 (en) Combination treatment of systemic fungal infections
KR20220058547A (ko) 감소된 독성을 갖는 하이브리드 암포테리신 b 유도체